Tradestie Institutional Equity Comparison Engine

COCH vs CERS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CERS Overall Edge

CERS Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cerus Corp (CERS) driven by superior Valuation, Options & Structure while COCH counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, COCH trades at N/M Forward P/E with -10261.0% operating margin (+57.1% YoY revenue) versus CERS at 123.3x Forward P/E and -1.1% operating margin (+9.5% YoY). In options structure, COCH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CERS sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CERS
COCH N/M vs CERS 123.3x Fwd P/E
Growth & Margin Winner COCH
Op Margin -10261.0% vs -1.1% ยท YoY +57.1% vs +9.5%
Momentum & Technical Winner COCH
1Y +843.4% vs +22.5% ยท 52W Pos 89% vs 19%
Options & Structure Winner CERS
UNCLASSIFIED (N/A IV) vs BREAKDOWN (32nd %ile IV)
COCH NASDAQ
Envoy Medical, Inc. Class A Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$6.70
+0.0% 1D
Market Cap $51.9M
1M Return +1024.35%
1Y Return +843.4%
Forward P/E N/M
Unified AI Score
35.1 / 100 SELL
Tech 50.0 Fund 27.0 Flow 50.0 Mom 40.0
CERS NASDAQ
Cerus Corp
Surgical & Medical Instruments & Apparatus
$1.85
-2.63% 1D
Market Cap $383.7M
1M Return -19.91%
1Y Return +22.52%
Forward P/E 123.3x
Unified AI Score
55.5 / 100 HOLD
Tech 60.0 Fund 64.0 Flow 66.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: COCH +843.4% CERS +22.52% Spread: +820.88 pp (COCH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period COCH Revenue CERS Revenue COCH Op. Margin CERS Op. Margin Margin Edge
FY2018 N/A $80M N/A -72.3% CERS
FY2019 N/A $90M N/A -70.6% CERS
FY2020 N/A $110M N/A -51.1% CERS
FY2021 N/A $160M N/A -30.7% CERS
FY2022 $0M $190M -3673.4% -18.1% CERS
FY2023 $0M $190M -5809.8% -16.1% CERS
FY2024 $0M $200M -8558.2% -7.1% CERS
FY2025 $0M $230M -9240.7% -3.7% CERS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: COCH (4) vs CERS (5)
Institutional Metric COCH CERS Criterion Row Winner
Market Capitalization Scale $51.9M $383.7M Larger Scale CERS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M 123.3x Lower Multiple CERS
Revenue Growth (YoY) Growth +57.1% +9.5% Higher Growth COCH
Operating Margin (TTM) Profitability -10261.0% -1.1% Higher Margin CERS
Net Profit Margin Profitability 0.0% -3.2% Higher Margin COCH
Return on Equity (ROE) Capital Efficiency 0.0% -10.7% Higher ROE COCH
52-Week Range Position Momentum 89% ($0โ€“$7) 19% ($1โ€“$3) Stronger Trend COCH
Beta / 30D Volatility Risk Regime 4.94ฮฒ ยท 3352% Vol 1.51ฮฒ ยท 76% Vol Lower Realized Risk CERS
Unified Institutional Score Composite Signal 35.1 / 100 (SELL) 55.5 / 100 (HOLD) Higher Composite CERS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full COCH vs CERS Buy Guide
COCH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COCH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CERS BREAKDOWN
122d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CERS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither COCH nor CERS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.